Breaking News Instant updates and real-time market news.

CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49

CymaBay initiated with an Overweight at Cantor

Cantor Fitzgerald analyst William Tanner started CymaBay Therapeutics with an Overweight rating and $16 price target. The analyst believes the company's seladelpar could become an important new therapy for primary biliary cholangitis and a possible treatment for non-alcoholic steatohepatitis.

  • 25

    Sep

  • 27

    Sep

CBAY CymaBay

09/14/17
OPCO
09/14/17
NO CHANGE
Target $15
OPCO
Outperform
Intercept Ocaliva dynamics highlight PBC opportunity, says Oppenheimer
Oppenheimer analyst Jay Olson says the Dear Doctor letter for Intercept's (ICPT) Ocaliva raises awareness of unmet medical need for patients with primary biliary cholangitis, or PBC. Since patients with Child-Pugh B/C cirrhosis were not studied in Ocaliva trials, the analyst believes the FDA's collaboration with Intercept to leverage PK modeling for dosing guidance which is included in the label and emphasized in the Dear Doctor letter highlights the importance of providing novel treatments to PBC patients. Olson expects these events to have a positive impact on the treatment of all PBC patients, and says CymaBay (CBAY) may benefit from these dynamics. He reiterates an Outperform rating and $15 price target on CymaBay's shares.
08/23/17
LEER
08/23/17
INITIATION
Target $12
LEER
Outperform
CymaBay initiated with an Outperform at Leerink
Leerink analyst Joseph Schwartz started CymaBay with an Outperform rating and $12 price target, noting that the company is currently developing seladelpar for the lead indication of primary biliary cholangitis, an autoimmune disease that causes progressive destruction of the bile ducts in the liver.
08/18/17
RHCO
08/18/17
INITIATION
RHCO
Buy
CymaBay initiated with a Buy at SunTrust
SunTrust analyst Edward Nash started coverage of CymaBay with a $15 price target and a Buy rating. He is upbeat on the outlook for the company's seladelpar, a treatment for a rare liver disease called primary biliary cholangitis. According to the analyst ,the drug has "well defined approvable endpoints and a primed commercial opportunity,"
08/11/17
IFSG
08/11/17
DOWNGRADE
Target $13
IFSG
Outperform
CymaBay downgraded to Outperform from Strong Buy at IFS Securities
IFS Securities analyst David Bouchey downgraded CymaBay to Outperform from Strong Buy, saying he sees now as a good time to step back with additional news flow not expected to pick until 2018. He lowered his price target on CymaBay to $13 from $18.

TODAY'S FREE FLY STORIES

M

Macy's

$26.26

0.67 (2.62%)

13:40
02/22/18
02/22
13:40
02/22/18
13:40
Options
Bullish three-way spread in Macy's ahead of earnings »

Bullish three-way spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 18

    Mar

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

, AVGO

Broadcom

$248.62

-1 (-0.40%)

13:36
02/22/18
02/22
13:36
02/22/18
13:36
Hot Stocks
Qualcomm announces letter sent to stockholders, video posted to site »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

AVGO

Broadcom

$248.62

-1 (-0.40%)

NXPI

NXP Semiconductors

$125.60

0.04 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

AUDVF

Audi AG

, VLKAY

Volkswagen

$40.43

-0.57 (-1.39%)

13:35
02/22/18
02/22
13:35
02/22/18
13:35
Periodicals
German prosecutors raid homes of former Audi board members, AFP says »

German prosecutors said…

AUDVF

Audi AG

VLKAY

Volkswagen

$40.43

-0.57 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$12.57

-0.0933 (-0.74%)

13:25
02/22/18
02/22
13:25
02/22/18
13:25
Conference/Events
Barrick Gold to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

13:25
02/22/18
02/22
13:25
02/22/18
13:25
Conference/Events
Morgan Stanley insurance analysts to hold an analyst/industry conference call »

Analysts host Charles…

13:20
02/22/18
02/22
13:20
02/22/18
13:20
General news
Treasury's $29 B 7-year sale was a disappointment »

Treasury's $29 B…

CSGP

CoStar Group

$352.11

0.27 (0.08%)

13:18
02/22/18
02/22
13:18
02/22/18
13:18
Recommendations
CoStar Group analyst commentary  »

Stephens would be buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 23

    May

$NSD

NASDAQ Market Internals

13:17
02/22/18
02/22
13:17
02/22/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
02/22/18
02/22
13:16
02/22/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
02/22/18
02/22
13:15
02/22/18
13:15
General news
Treasury Action: yields kicked up from lows »

Treasury Action: yields…

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

, NKTR

Nektar

$86.45

3 (3.60%)

13:11
02/22/18
02/22
13:11
02/22/18
13:11
Hot Stocks
Analyst cuts Alkermes rating as cancer drug seems less effective than competitor »

Shares of Alkermes (ALKS)…

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

NKTR

Nektar

$86.45

3 (3.60%)

BMY

Bristol-Myers

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 05

    Mar

  • 08

    Mar

  • 04

    Apr

  • 03

    May

CIDM

Cinedigm

$1.25

0.0201 (1.63%)

13:10
02/22/18
02/22
13:10
02/22/18
13:10
Hot Stocks
Cinedigm acquires North American rights to 'Class Rank' »

Cinedigm Corp has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

FB

Facebook

$177.91

1.9 (1.08%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Technical Analysis
Technical Take: Facebook trades near session lows »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

HPQ

HP Inc.

$21.52

0.345 (1.63%)

, LNVGY

Lenovo

$10.15

-0.01 (-0.10%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Earnings
On The Fly: What to watch for in HP Inc.'s earnings report »

HP Inc. (HPQ) is…

HPQ

HP Inc.

$21.52

0.345 (1.63%)

LNVGY

Lenovo

$10.15

-0.01 (-0.10%)

AAPL

Apple

$171.07

-0.78 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 26

    Feb

  • 24

    Apr

  • 30

    May

MIC

Macquarie Infrastructure

$39.09

-24.53 (-38.56%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Recommendations
Macquarie Infrastructure analyst commentary  »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BAMXY

BMW Group

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Hot Stocks
BMW to pay $2.2M to settle DOJ claims of SCRA violations »

The Justice Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
02/22/18
02/22
13:05
02/22/18
13:05
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:05
02/22/18
02/22
13:05
02/22/18
13:05
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

W

Wayfair

$74.55

-21.14 (-22.09%)

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Recommendations
Wayfair analyst commentary  »

Citi trims Wayfair target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EAT

Brinker

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Options
Brinker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$33.03

-0.95 (-2.80%)

, VIA

Viacom

$38.35

-1.15 (-2.91%)

13:04
02/22/18
02/22
13:04
02/22/18
13:04
Hot Stocks
SEGA, Paramount announce agreement to co-produce Sonic the Hedgehog feature film »

SEGA Holdings announced…

VIAB

Viacom

$33.03

-0.95 (-2.80%)

VIA

Viacom

$38.35

-1.15 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

GOOGL

Alphabet Class A

$1,113.75

10.16 (0.92%)

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Technical Analysis
Technical Take: Alphabet Class A moves lower in intraday rounding pattern »

The shares have dropped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

DPS

Dr Pepper Snapple

$115.28

-0.1 (-0.09%)

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Options
Dr Pepper Snapple put volume heavy and directionally bearish »

Bearish flow noted in Dr…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
02/22/18
02/22
12:55
02/22/18
12:55
General news
Treasury Option Action: a rash of put buying »

Treasury Option Action: a…

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Conference/Events
CFA Society of Milwaukee to hold a luncheon discussion »

Bill Stone, CMT of PNC…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.